Diabetes: Lecture 5 Flashcards

1
Q

best way to asses Diabetes?

A

Combo of A1c, BG or Continuous glucose monitoring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Using A1c test frequency

A

every 3 months of not at goal

every 6 months in pt meeting goal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Limitation of A1c

A

does not provide a measure of glycemic variability or hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Time in range goal?

A

> 70%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Coefficient of variation Goal?

A

= 36%

measure of glucose variability ie Roller-coaster

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hypoglycemia

A

Defined as BG < 70

Rapid onset and progression of Symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Classification of Hypoglycemia

A

Lvl 1 = <70 >54
Lvl 2 = < 54
Lvl 3 = altered mental and/or physical status requiring assistance for treatment of hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cause of neurogenic symptoms of Hypoglycemia

A

Due to activation of autonomic nervous system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cause of neuroglucopenic symptoms of Hypoglycemia

A

Due to inadequate glucose to the brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How to treat mild to moderate hypoglycemia, pt can swallow.

A
Use 15 grams of glucose from carbs....
3-5 hard candy
4 oz juice
3-4 glucose tablets
soda

check after 15 min and if still under <70, repeat. Follow up with a snack after

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How to treat severe hypoglycemia, cant safety swallow or unconscious

A
GlucaGen = injection
Evoke = injection
Baqsimi = spray nose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Diabetic Ketoacidosis defining features

A

Hyperglycemia
Ketosis
Metabolic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Who gets DKA?

A

usually Type 1

often how we diagnose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

DKA presenting features?

A
Fatigue
Headache
Polyuria
Polydipsia
Weight loss
Nausea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Labs of someone with DKA?

A

Glucose >250
Low serum bicarb <18
Low arterial pH <7.3
Ketonemia and moderate ketonuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

DKA complications

A

Cerebral edema (often kids)
Respiratory distress syndrome
Thromboembolism
Rhabdomyolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

DKA management

A
Fluid admin
Insulin replacement
Potassium replacement
Do a work-up
Monitor pt
Educate/Follow-up
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

HHS

A

Hyperosmolar Hyperglycemic state

Often seen in Type 2 Diabetes

don’t see the ketones, but dehydration is more profound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

HHS defining features?

A

Hyperglycemia
Hyperosmolality
Dehydration

20
Q

HHS onset?

A

Days to weeks

21
Q

Labs for HHS

A

Glucose >600

Plasma osmolality >320 mOsm/kg

22
Q

Presenting Symptoms HHS

A

Polyuria
Polydipsia
*Neurological signs
Dehydration

23
Q

Big differences between DKA and HHS?

A

Glucose and Ketones (Neg for HHS, Pos for DKA)

24
Q

Macrovascular diseases

A

Cerebrovascular disease

Coronary Heart Disease

25
Microvascualr diseases
Retinopathy Nephropathy Neuropathy PVD
26
Landmark Trials Diabetes
``` DCCT = Type 1 UKPDS = Type 2 ``` Helped establish glucose control for A1C <7%
27
Take home points of DCCT and UKPDS
Improved glycemic control is associated with decreased rates of microvascular complications no sig correlation between tight glycemic control and reduction of CVD events Long term follow up suggests that there is reduction in CVD events with tighter control
28
Trials to compare effects of intensive vs standard glycemic control on CVD outcomes in high risk patients with Type 2 diabetes?
Accord Advance VADT
29
ACCORD, ADVANCE, VADT
No sig risk reduction in microvascular events with tight glucose control reduction in microvascular complications, but sig increase hypoglycemic events Intensive treatment associated with increase all-cause mortality (ACCORD) Neutral or increased risk of CV events n ACCORD
30
Cardiovascular risk factors w/ Diabetes
``` Dyslipidemia Hypertension Smoking Obesity/overweight CKD Presence of albuminuria ```
31
1st line for Hypertension w/ Diabetes
ACE, ARB, Thiazide, DHP CCB monitor eGFR, Scr and K on ACE/ARB
32
Lipid screening w/ Diabetes
every 5 years <40 not on statin
33
Lipid Treatment w/ Diabetes
Primary prevention: aged 40-75 should be on Moderate statin unless contraindicated, if high risk use high intensity 2ndary prevention: any age, high intensity statin
34
high intensity statins
Atorvastatin 40-80mg | Rosuvastatin 20-40mg
35
When to use Aspirin in patients with DM
2ndary prevention = recommended with h/o ASCVD event controversial in primary prevention, can be considered but have to do pro/con
36
Who would not likely be recommended aspirin
DM pt that's <50 yr old and not for those >70yrs old
37
Screening for Diabetic Kidney Disease
Type 1 = Typically develops after ~10yrs of diabetes, screen after 5 Type 2 = start screening at diagnosis
38
Decreasing eGFR and Increasing Albuminuria causes an......... in risk of Cardiovascular death
Increase
39
Treatment of Diabetic Kidney Disease
ACE or ARB recommended for Hypertension with Albuminuria SGLT2i regardless of glycemic control GLP1-RA (for benefit) *can use NSMineralocrticid RA Finerenone if unable to use SGLT2i*
40
Diabetic Retinopathy prevalence strongly related to.....
duration of diabetes and level of glycemic control
41
Retinopathy screening
Annual eye exam Type 1 - 5 years after diagnosis Type 2 - start at diagnosis
42
Retinopathy treatment
Non to reverse it can try laser or VEGF therapy
43
Diabetic Peripheral Neuropathy
diminished perception of vibration, pain, temp in lower extremities Lea to ulcers and amputations
44
Best way to prevent Diabetic Neuropathy
Glycemic control cant reverse
45
Diabetic Peripheral Neuropathy screening
Type 1 - 5 years after diagnosis | Type 2 - start at diagnosis, annually
46
How to assess Diabetic Peripheral Neuropathy
Pinprick Temp Vibration perception Pressure sensation
47
Diabetic Peripheral Neuropathy treatment
Pregabalin Duloxetine Gabapentin (off-label)